现代中西医结合杂志
現代中西醫結閤雜誌
현대중서의결합잡지
MODERN JOURNAL OF INTEGRATED TRADITIONAL CHINESE AND WESTERN MEDICINE
2014年
21期
2292-2293,2394
,共3页
恩替卡韦%地五养肝方%乙型肝炎病毒相关性肾炎%白介素-2%γ-干扰素
恩替卡韋%地五養肝方%乙型肝炎病毒相關性腎炎%白介素-2%γ-榦擾素
은체잡위%지오양간방%을형간염병독상관성신염%백개소-2%γ-간우소
entecavir%Diwu Yanggan anagraph%hepatitis B virus associated nephritis%interleukin-2%interferon-γ
目的:观察地五养肝方联合恩替卡韦治疗乙型肝炎病毒相关性肾炎( HBV-GN)的疗效及其对白介素-2( IL-2)、γ-干扰素( IFN-γ)的影响。方法21例HBV-GN患者予以地五养肝方联合恩替卡韦治疗36周,观察患者临床症状、体征,检测患者肝肾功能、24 h尿蛋白定量、HBV DNA水平及血清IL-2、IFN-γ水平等。结果治疗36周后,HBV-GN患者临床症状、体征、肝肾功能较前明显改善(P均<0.01);总有效率86%,HBV DNA转阴率81%;血清IL-2、IFN-γ水平较治疗前明显升高( P均<0.01)。结论恩替卡韦联合地五养肝方治疗HBV-GN疗效显著,其作用机制可能与高效抗病毒、调节机体的免疫功能及减少肝肾的免疫损伤等有关。
目的:觀察地五養肝方聯閤恩替卡韋治療乙型肝炎病毒相關性腎炎( HBV-GN)的療效及其對白介素-2( IL-2)、γ-榦擾素( IFN-γ)的影響。方法21例HBV-GN患者予以地五養肝方聯閤恩替卡韋治療36週,觀察患者臨床癥狀、體徵,檢測患者肝腎功能、24 h尿蛋白定量、HBV DNA水平及血清IL-2、IFN-γ水平等。結果治療36週後,HBV-GN患者臨床癥狀、體徵、肝腎功能較前明顯改善(P均<0.01);總有效率86%,HBV DNA轉陰率81%;血清IL-2、IFN-γ水平較治療前明顯升高( P均<0.01)。結論恩替卡韋聯閤地五養肝方治療HBV-GN療效顯著,其作用機製可能與高效抗病毒、調節機體的免疫功能及減少肝腎的免疫損傷等有關。
목적:관찰지오양간방연합은체잡위치료을형간염병독상관성신염( HBV-GN)적료효급기대백개소-2( IL-2)、γ-간우소( IFN-γ)적영향。방법21례HBV-GN환자여이지오양간방연합은체잡위치료36주,관찰환자림상증상、체정,검측환자간신공능、24 h뇨단백정량、HBV DNA수평급혈청IL-2、IFN-γ수평등。결과치료36주후,HBV-GN환자림상증상、체정、간신공능교전명현개선(P균<0.01);총유효솔86%,HBV DNA전음솔81%;혈청IL-2、IFN-γ수평교치료전명현승고( P균<0.01)。결론은체잡위연합지오양간방치료HBV-GN료효현저,기작용궤제가능여고효항병독、조절궤체적면역공능급감소간신적면역손상등유관。
Objective It is to observe the effect of entecavir combined with Diwu Yanggan anagraph ( DWYGA) in treat-ment of hepatitis B virus associated nephritis ( HBV-GN) and its influence on IL-2 and IFN-γ.Methods 21 patients with HBV-GN were received entecavir combined with DWYGA for at least 36 weeks.The changes of clinical symptom and signs , liver and kidney function , 24hUAlb, HBV DNA, IL-2 and IFN-γwere observed.Results Compared with pre -therapy, the clinical symptom and signs, liver and kidney function of patients with HBV -GN were markedly improved (P<0.01). The total effective rate was 86%, HBVDNA negative rate was 81%.The levels of IL-2 and IFN-γwere markedly height-ened than pre-therapy ( P<0.01 ) .Conclusion The combined therapy with entecavir and DWYGA is effective for HBV -GN.The mechanism may be relevant to efficient anti -virus, regulate the body’s immune function, and reduce the damage on kidney and liver .